Driving Advancements in Biopharmaceutical Manufacturing

PAK BioSolutions Founded

Oct 05 2018

Fairfax, VA, October 5, 2018 – PAK BioSolutions, Inc. was recently founded and today welcomes on board Vice-President and co-founder Kevin Hill-Byrne.  The company’s mission is to provide comprehensive solutions for end-to-end continuous manufacture of biopharmaceuticals with increased productivity, lower capital costs and a smaller footprint.  The company will offer automated systems for batch sizes that range from 2-20,000 liters of cell culture and a proprietary disposable flow kit.  The first system, planned for release in 2020, is a pilot scale unit for purification of 50 to 500 liters of cell culture.

Previously, President and co-founder Joanna Pezzini developed the continuous purification lab at AstraZeneca along with co-founder Kevin Hill-Byrne and board member Lindsay Arnold. “We are developing the system we wished we had available to us, but didn’t.  We wanted to create a complete package so that each company doesn’t need to develop an entire system from the ground up.”

Kevin Hill-Byrne will lead the automation efforts, a significant undertaking for an end-to-end system.  All process steps need to not only work independently, but in sync with all other stages of the system to achieve a consistent mass flow rate from the bioreactor through to the final UFDF steps.  “I am thrilled to have Kevin working on this project – his automation experience is practically tailored to our company’s needs,” said Joanna Pezzini.

Recent Post

NOW AVAILABLE Pilot Scale PAK System

Demo, lease or purchase The PAK System. Receive your custom quote now.

Request quote